By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aduro Biotech 

626 Bancroft Way
Suite 3C
Berkeley  California  94710  U.S.A.
Phone: 510-848-4400 Fax: n/a




Company News
Aduro Biotech (ADRO) To Present At J.P. Morgan Healthcare Conference 1/8/2016 8:01:04 AM
Aduro Biotech (ADRO) To Present At Oppenheimer Healthcare Conference 12/2/2015 11:20:38 AM
Aduro Biotech (ADRO) To Present At NASDAQ Investor Conference 11/30/2015 11:04:21 AM
Aduro Biotech (ADRO) Confirms All Clinical Trials Continue Unaltered And As Planned 11/25/2015 10:05:33 AM
Aduro Biotech (ADRO) Drops After Quietly Disclosing Patient in Top Phase II Program Developed Serious Infection 11/24/2015 11:57:08 AM
Aduro Biotech (ADRO) Announces Third Quarter 2015 Financial Results 11/23/2015 10:26:18 AM
Aduro Biotech (ADRO) Receives Orphan Drug Designation In The European Union For CRS-207 For The Treatment Of Mesothelioma 11/23/2015 10:24:09 AM
Aduro Biotech (ADRO) Europe‚Äôs Chief Scientific Officer, Andrea Van Elsas, Ph.D. Featured As Keynote Speaker On Immunomodulatory Antibodies At ESMO Symposium On Immuno-Oncology 2015 11/20/2015 9:41:23 AM
Aduro Biotech (ADRO) Establishes European Subsidiary 11/20/2015 7:51:41 AM
Aduro Biotech (ADRO) Receives Milestone Payment From Janssen Pharmaceutical For Submission Of Investigational New Drug Application For ADU-741 In Prostate Cancer 11/18/2015 7:26:03 AM